152 Monitoring of low & intermediate risk DTC patients in the first 5 years after initial treatment

Session 152 - Monitoring of low and intermediate risk papillary and follicular thyroid cancer patients in the first five years after initial treatment(s). Presented by Sana Ghaznavi, MD, Endocrinologist. This video was recorded during the 26th International Thyroid Cancer Survivors' Conference that was held Oct 13-15, 2023 in Denver, Colorado, USA. This event was hosted by ThyCa: Thyroid Cancer Survivors' Association, Inc. The content is not to be used as medical advice, but rather as education. Please seek the care of your own medical team.